Search Results for: 3-person

Nature Biased News Coverage of 3-Person IVF

Screen-Shot-2015-02-13-at-1.02.20-PM

NatureNews is a science news outlet so I’ve been wondering what the heck the deal is with their strongly biased news coverage of the mitochondrial transfer 3-person IVF technology debate. By way of context, I like NatureNews and am a regular reader, but their coverage of the mitochondrial transfer debate has been completely one-sided and inaccurate. Their […]

Nature Biased News Coverage of 3-Person IVF Read More »

Weekly reads: BioViva & life-extension clinic, RMATs, universal cells

BioViva CEO Liz Parrish in YouTube video.

I’ve written before about Liz Parrish and her life-extension firm BioViva. Now they appear to have connections with another entity called Integrated Health Systems or IHS, according to a new Wired article. Some of what is going on with IHS and maybe BioViva in Mexico seems extremely risky to me. BioViva, Parrish, and Integrated Health Systems The

Weekly reads: BioViva & life-extension clinic, RMATs, universal cells Read More »

Ukraine clinic plans to sell CRISPR enhancements: hair color, skin, & breast size

medeus clinic crispr enhancements

It was a couple of years back that researcher He Jiankui claimed he made three “CRISPR babies.” No one would think about doing any kind of rogue gene-editing again, right? Not even somatic gene edits. After all, as far as we know he’s in jail. We still don’t know the health risks that these three

Ukraine clinic plans to sell CRISPR enhancements: hair color, skin, & breast size Read More »

20/20 vision? The Niche’s 20 stem cell & regenerative medicine predictions for 2020

The-Niche-stem-cell-predictions-2020

Every year in December and early January I do a post predicting some key events for the stem cell and regenerative medicine field for the upcoming year and today’s post contains my predictions for 2020. You can see my past 2019 predictions along with my grades for them here. I gave myself a B+ for

20/20 vision? The Niche’s 20 stem cell & regenerative medicine predictions for 2020 Read More »

When the state & ‘rogue’ scientists collide: case of China & CRISPR baby guy He Jiankui (贺建奎)

He-Jiankui-贺建奎

What happens next to He Jiankui (贺建奎) or as some people now refer to him, the “CRISPR baby guy”? China has a challenging situation to resolve here, but such conflicts between scientists and governments have happened regularly in history. When scientists go “rogue” (i.e. don’t conform to norms or ethical standards in an extreme way or

When the state & ‘rogue’ scientists collide: case of China & CRISPR baby guy He Jiankui (贺建奎) Read More »

Perspectives on uncritical NYT coverage of cardiac mitochondrial transplant trial

mitochondrial-transplant-for-heart

One of the reasons I’m a scientist is that I find biology fascinating and admittedly novel biomedical science can really catch my eye, but more recently as a somewhat grizzled researcher, I’ve become increasingly skeptical about some “sexy” research and media coverage of it. A small red flag went up for me as I was

Perspectives on uncritical NYT coverage of cardiac mitochondrial transplant trial Read More »

CRISPR, human genetic modification, & a needed course correction

coverGMO-e1498086048321

Are designer babies made using CRISPR or other genetic modification technologies closer to reality today? If so, what exactly should we do about it? Researchers can use CRISPR to genetically modify just about any organism or its cells, but targeting humans is the subject of the most intense discussion including using CRISPR in the human germline

CRISPR, human genetic modification, & a needed course correction Read More »

Grading my stem cell predictions for 2016: how’d I do?

stem-cell-predictions

Below are the 2016 stem cell predictions I made last year and their status now color-coded near year’s end. Green is right, orange is mixed bag, and red is flat out wrong. Overall, I did better than most past years with only having entirely blown it on four. Stay tuned later this week for my 2017 predictions,

Grading my stem cell predictions for 2016: how’d I do? Read More »